Carlos São-José concluded his PhD in Biology (Molecular Biology) in 2002, Faculty of Sciences, University of Lisbon (FCULisboa). Between 2002-2008, he conducted his post-doctoral studies at FCULisboa and at Laboratoire de Virologie Moléculaire et Structurale, CNRS-Gif-sur-Yvette, France. During 2008-2010 he held a position of Principal Investigator in the field of molecular microbiology at IMM-Institute of Molecular Medicine, Lisbon, in accumulation with the role of Business Unit Scientific Manager at the biotech company Technophage, SA. In 2010, C. São-José was appointed professor of microbiology at Faculty of Pharmacy, University of Lisbon (FFULisboa), where he currently teaches different subjects in the areas of infectious diseases and molecular microbiology. Between 2010-2014, he headed the Phage and Bacteria Molecular Biology Group at CPM-URIA, FFULisboa. C. São-José joined iMed in 2014, leading a research team within the M2B group. After iMed reorganization in 2021, C. São-José and M. Pimentel created the PhaBRIC lab. São-José studies have been secured through competitive funding and have focused on phage/bacteria interactions, both with fundamental and applied purposes. Major research interests include the molecular and biophysical bases governing phage genome delivery to host bacteria, and the action and regulation of the proteins that phages employ to compromise the bacterial cell envelope. The generated knowledge has been explored to devise phage-derived products to fight antibiotic-resistant bacteria. C. São-José research contributed to over 40 publications, including peer-reviewed articles, book chapters and patents. C. Sao-José has been supervising the research of post-doctoral scientists and of PhD and Master students.